Stephen Taub For Members Only RA Capital Management, Janus Henderson, Balyasny Back Reverse Merger of Biotech Company Newly formed Ambros Therapeutics will go public by merging with a Nasdaq-listed penny stock. Stephen Taub September 3, 2026